We are live on ! Find out more
SCLN

Sciclone Pharmaceuticals Inc
SCLN

Delisted

SCLN was delisted on the 13th of October, 2017.

Back to rankings

116 hedge funds and large institutions have $213M invested in Sciclone Pharmaceuticals Inc in 2014 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 7

52% more capital invested

Capital invested by funds: $141M → $213M (+$72.9M)

22% more funds holding

Funds holding: 95 → 116 (+21)

18% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 34

21% less call options, than puts

Call options by funds: $615K | Put options by funds: $778K

Holders
116
Holders Change
+21
Holders Change %
+22.11%
% of All Funds
3.37%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
28
Increased
40
Reduced
34
Closed
7
Calls
$615K
Puts
$778K
Net Calls
-$163K
Net Calls Change
-$409K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$4.56M
2
OAM
Oxford Asset Management
United Kingdom
+$4.26M
3
Morgan Stanley
Morgan Stanley
New York
+$1.82M
4
CAM
ClariVest Asset Management
California
+$1.72M
5
MC
Menta Capital
California
+$1.67M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$2.44M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.41M
3
LSV Asset Management
LSV Asset Management
Illinois
-$875K
4
Bank of America
Bank of America
North Carolina
-$725K
5
BIT
BlackRock Institutional Trust
California
-$723K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$1.47M -$34.3K -5,732 -3%
Two Sigma Advisers
27
Two Sigma Advisers
New York
$1.46M +$401K +67,000 +46%
TC
28
TFS Capital
Pennsylvania
$1.44M +$1.25M +208,800 New
Charles Schwab
29
Charles Schwab
California
$1.38M +$500K +83,454 +72%
SCM
30
Sterling Capital Management
North Carolina
$1.36M +$1.19M +197,872 New
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$1.35M +$590K +98,431 +102%
DC
32
Deere & Company
Illinois
$1.29M +$1.12M +187,418 New
PAAMCP
33
Pacific Alternative Asset Management Company (PAAMCO)
California
$1.28M +$1.12M +186,310 New
NI
34
Numeric Investors
Massachusetts
$1.28M +$1.11M +185,500 New
State Board of Administration of Florida Retirement System
35
State Board of Administration of Florida Retirement System
Florida
$1.28M +$705K +117,587 +174%
BCM
36
Bridgeway Capital Management
Texas
$1.15M – – –
Millennium Management
37
Millennium Management
New York
$1.14M +$612K +102,159 +162%
BIM
38
BlackRock Investment Management
Delaware
$1.09M -$1.15K -192 -0.1%
CCM
39
Cadence Capital Management
Massachusetts
$1.07M +$929K +155,010 New
GCP
40
GSA Capital Partners
United Kingdom
$826K -$59.8K -9,981 -8%
KCM
41
Kennedy Capital Management
Missouri
$807K +$389K +64,989 +125%
SAM
42
Shell Asset Management
Netherlands
$750K +$60.9K +10,162 +10%
Norges Bank
43
Norges Bank
Norway
$744K -$647K -107,991 -50%
PPA
44
Parametric Portfolio Associates
Washington
$696K +$357K +59,635 +144%
AllianceBernstein
45
AllianceBernstein
Tennessee
$680K -$18.6K -3,100 -3%
SO
46
STRS Ohio
Ohio
$679K -$213K -35,600 -27%
RIM
47
Ranger Investment Management
Texas
$674K +$587K +97,880 New
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$655K +$6.23K +1,040 +1%
Citadel Advisors
49
Citadel Advisors
Florida
$640K -$72.6K -12,120 -12%
CS
50
Credit Suisse
Switzerland
$636K +$79.4K +13,246 +17%
1
2
3 4 5

SCLN Hedge Fund Activity: Q3 2014 in Review

116 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q3 2014, worth a combined $213M — up 52% from $141M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new SCLN positions and 7 closed out — a net gain of 21 holders — while 40 added to existing stakes and 34 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $4.56M. The largest seller was Franklin Resources, cutting an estimated $2.44M.

  • 116 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q3 2014, up from 95 in Q2 2014.
  • Funds reported $213M of Sciclone Pharmaceuticals Inc stock for Q3 2014, up 52% quarter-over-quarter.
  • 28 funds opened new Sciclone Pharmaceuticals Inc positions in Q3 2014 and 7 closed out, a net change of +21 holders.
  • The largest Sciclone Pharmaceuticals Inc buyer in Q3 2014 was Acadian Asset Management, an estimated $4.56M added.
  • The largest Sciclone Pharmaceuticals Inc seller in Q3 2014 was Franklin Resources, an estimated $2.44M sold.

Based on aggregated 13F filings for Q3 2014.